Global Opioid Induced Side Effects Treatment Market Insights and Forecast to 2028

  • Report ID:238616
  • Industry Name: Pharma & Healthcare
  • Publishing Date: Jun-22
  • No. of Pages: 98
                              
Opioid Induced Side Effects Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Opioid Induced Side Effects Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Risperidone Methylphenidate Cetirizine Other Segment by Application Drug Overdose Treatment Pain Treatment Other By Company Shionogi Cubist Pharmaceuticals SLA Pharma AstraZeneca AIKO Biotechnology Progenics Pharmaceuticals By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Risperidone 1.2.3 Methylphenidate 1.2.4 Cetirizine 1.2.5 Other 1.3 Market by Application 1.3.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Drug Overdose Treatment 1.3.3 Pain Treatment 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Opioid Induced Side Effects Treatment Market Perspective (2017-2028) 2.2 Opioid Induced Side Effects Treatment Growth Trends by Region 2.2.1 Opioid Induced Side Effects Treatment Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Opioid Induced Side Effects Treatment Historic Market Size by Region (2017-2022) 2.2.3 Opioid Induced Side Effects Treatment Forecasted Market Size by Region (2023-2028) 2.3 Opioid Induced Side Effects Treatment Market Dynamics 2.3.1 Opioid Induced Side Effects Treatment Industry Trends 2.3.2 Opioid Induced Side Effects Treatment Market Drivers 2.3.3 Opioid Induced Side Effects Treatment Market Challenges 2.3.4 Opioid Induced Side Effects Treatment Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Opioid Induced Side Effects Treatment Players by Revenue 3.1.1 Global Top Opioid Induced Side Effects Treatment Players by Revenue (2017-2022) 3.1.2 Global Opioid Induced Side Effects Treatment Revenue Market Share by Players (2017-2022) 3.2 Global Opioid Induced Side Effects Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Opioid Induced Side Effects Treatment Revenue 3.4 Global Opioid Induced Side Effects Treatment Market Concentration Ratio 3.4.1 Global Opioid Induced Side Effects Treatment Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Side Effects Treatment Revenue in 2021 3.5 Opioid Induced Side Effects Treatment Key Players Head office and Area Served 3.6 Key Players Opioid Induced Side Effects Treatment Product Solution and Service 3.7 Date of Enter into Opioid Induced Side Effects Treatment Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Opioid Induced Side Effects Treatment Breakdown Data by Type 4.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Type (2017-2022) 4.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Type (2023-2028) 5 Opioid Induced Side Effects Treatment Breakdown Data by Application 5.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Application (2017-2022) 5.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Opioid Induced Side Effects Treatment Market Size (2017-2028) 6.2 North America Opioid Induced Side Effects Treatment Market Size by Type 6.2.1 North America Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) 6.2.2 North America Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) 6.2.3 North America Opioid Induced Side Effects Treatment Market Share by Type (2017-2028) 6.3 North America Opioid Induced Side Effects Treatment Market Size by Application 6.3.1 North America Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) 6.3.2 North America Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) 6.3.3 North America Opioid Induced Side Effects Treatment Market Share by Application (2017-2028) 6.4 North America Opioid Induced Side Effects Treatment Market Size by Country 6.4.1 North America Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) 6.4.2 North America Opioid Induced Side Effects Treatment Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Opioid Induced Side Effects Treatment Market Size (2017-2028) 7.2 Europe Opioid Induced Side Effects Treatment Market Size by Type 7.2.1 Europe Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) 7.2.2 Europe Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) 7.2.3 Europe Opioid Induced Side Effects Treatment Market Share by Type (2017-2028) 7.3 Europe Opioid Induced Side Effects Treatment Market Size by Application 7.3.1 Europe Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) 7.3.2 Europe Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) 7.3.3 Europe Opioid Induced Side Effects Treatment Market Share by Application (2017-2028) 7.4 Europe Opioid Induced Side Effects Treatment Market Size by Country 7.4.1 Europe Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) 7.4.2 Europe Opioid Induced Side Effects Treatment Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size (2017-2028) 8.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type 8.2.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Opioid Induced Side Effects Treatment Market Share by Type (2017-2028) 8.3 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application 8.3.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Opioid Induced Side Effects Treatment Market Share by Application (2017-2028) 8.4 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region 8.4.1 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Opioid Induced Side Effects Treatment Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Opioid Induced Side Effects Treatment Market Size (2017-2028) 9.2 Latin America Opioid Induced Side Effects Treatment Market Size by Type 9.2.1 Latin America Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) 9.2.2 Latin America Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) 9.2.3 Latin America Opioid Induced Side Effects Treatment Market Share by Type (2017-2028) 9.3 Latin America Opioid Induced Side Effects Treatment Market Size by Application 9.3.1 Latin America Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) 9.3.2 Latin America Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) 9.3.3 Latin America Opioid Induced Side Effects Treatment Market Share by Application (2017-2028) 9.4 Latin America Opioid Induced Side Effects Treatment Market Size by Country 9.4.1 Latin America Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) 9.4.2 Latin America Opioid Induced Side Effects Treatment Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Opioid Induced Side Effects Treatment Market Size (2017-2028) 10.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type 10.2.1 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Type (2017-2028) 10.3 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application 10.3.1 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Opioid Induced Side Effects Treatment Market Share by Application (2017-2028) 10.4 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country 10.4.1 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Opioid Induced Side Effects Treatment Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Shionogi 11.1.1 Shionogi Company Details 11.1.2 Shionogi Business Overview 11.1.3 Shionogi Opioid Induced Side Effects Treatment Introduction 11.1.4 Shionogi Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) 11.1.5 Shionogi Recent Developments 11.2 Cubist Pharmaceuticals 11.2.1 Cubist Pharmaceuticals Company Details 11.2.2 Cubist Pharmaceuticals Business Overview 11.2.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Introduction 11.2.4 Cubist Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) 11.2.5 Cubist Pharmaceuticals Recent Developments 11.3 SLA Pharma 11.3.1 SLA Pharma Company Details 11.3.2 SLA Pharma Business Overview 11.3.3 SLA Pharma Opioid Induced Side Effects Treatment Introduction 11.3.4 SLA Pharma Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) 11.3.5 SLA Pharma Recent Developments 11.4 AstraZeneca 11.4.1 AstraZeneca Company Details 11.4.2 AstraZeneca Business Overview 11.4.3 AstraZeneca Opioid Induced Side Effects Treatment Introduction 11.4.4 AstraZeneca Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) 11.4.5 AstraZeneca Recent Developments 11.5 AIKO Biotechnology 11.5.1 AIKO Biotechnology Company Details 11.5.2 AIKO Biotechnology Business Overview 11.5.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Introduction 11.5.4 AIKO Biotechnology Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) 11.5.5 AIKO Biotechnology Recent Developments 11.6 Progenics Pharmaceuticals 11.6.1 Progenics Pharmaceuticals Company Details 11.6.2 Progenics Pharmaceuticals Business Overview 11.6.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Introduction 11.6.4 Progenics Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) 11.6.5 Progenics Pharmaceuticals Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Risperidone Table 3. Key Players of Methylphenidate Table 4. Key Players of Cetirizine Table 5. Key Players of Other Table 6. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Opioid Induced Side Effects Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Opioid Induced Side Effects Treatment Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Opioid Induced Side Effects Treatment Market Share by Region (2017-2022) Table 10. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Opioid Induced Side Effects Treatment Market Share by Region (2023-2028) Table 12. Opioid Induced Side Effects Treatment Market Trends Table 13. Opioid Induced Side Effects Treatment Market Drivers Table 14. Opioid Induced Side Effects Treatment Market Challenges Table 15. Opioid Induced Side Effects Treatment Market Restraints Table 16. Global Opioid Induced Side Effects Treatment Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Opioid Induced Side Effects Treatment Revenue Share by Players (2017-2022) Table 18. Global Top Opioid Induced Side Effects Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Side Effects Treatment as of 2021) Table 19. Ranking of Global Top Opioid Induced Side Effects Treatment Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Opioid Induced Side Effects Treatment Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Opioid Induced Side Effects Treatment Product Solution and Service Table 23. Date of Enter into Opioid Induced Side Effects Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2017-2022) Table 27. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2023-2028) Table 29. Global Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Opioid Induced Side Effects Treatment Revenue Share by Application (2017-2022) Table 31. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Opioid Induced Side Effects Treatment Revenue Share by Application (2023-2028) Table 33. North America Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Opioid Induced Side Effects Treatment Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Opioid Induced Side Effects Treatment Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Opioid Induced Side Effects Treatment Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Opioid Induced Side Effects Treatment Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Opioid Induced Side Effects Treatment Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Opioid Induced Side Effects Treatment Market Size by Country (2023-2028) & (US$ Million) Table 63. Shionogi Company Details Table 64. Shionogi Business Overview Table 65. Shionogi Opioid Induced Side Effects Treatment Product Table 66. Shionogi Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) & (US$ Million) Table 67. Shionogi Recent Developments Table 68. Cubist Pharmaceuticals Company Details Table 69. Cubist Pharmaceuticals Business Overview Table 70. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product Table 71. Cubist Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) & (US$ Million) Table 72. Cubist Pharmaceuticals Recent Developments Table 73. SLA Pharma Company Details Table 74. SLA Pharma Business Overview Table 75. SLA Pharma Opioid Induced Side Effects Treatment Product Table 76. SLA Pharma Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) & (US$ Million) Table 77. SLA Pharma Recent Developments Table 78. AstraZeneca Company Details Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Opioid Induced Side Effects Treatment Product Table 81. AstraZeneca Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) & (US$ Million) Table 82. AstraZeneca Recent Developments Table 83. AIKO Biotechnology Company Details Table 84. AIKO Biotechnology Business Overview Table 85. AIKO Biotechnology Opioid Induced Side Effects Treatment Product Table 86. AIKO Biotechnology Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) & (US$ Million) Table 87. AIKO Biotechnology Recent Developments Table 88. Progenics Pharmaceuticals Company Details Table 89. Progenics Pharmaceuticals Business Overview Table 90. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product Table 91. Progenics Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2017-2022) & (US$ Million) Table 92. Progenics Pharmaceuticals Recent Developments Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Global Opioid Induced Side Effects Treatment Market Share by Type: 2021 VS 2028 Figure 2. Risperidone Features Figure 3. Methylphenidate Features Figure 4. Cetirizine Features Figure 5. Other Features Figure 6. Global Opioid Induced Side Effects Treatment Market Share by Application: 2021 VS 2028 Figure 7. Drug Overdose Treatment Case Studies Figure 8. Pain Treatment Case Studies Figure 9. Other Case Studies Figure 10. Opioid Induced Side Effects Treatment Report Years Considered Figure 11. Global Opioid Induced Side Effects Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Opioid Induced Side Effects Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Opioid Induced Side Effects Treatment Market Share by Region: 2021 VS 2028 Figure 14. Global Opioid Induced Side Effects Treatment Market Share by Players in 2021 Figure 15. Global Top Opioid Induced Side Effects Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Side Effects Treatment as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Opioid Induced Side Effects Treatment Revenue in 2021 Figure 17. North America Opioid Induced Side Effects Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2028) Figure 19. North America Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2028) Figure 20. North America Opioid Induced Side Effects Treatment Market Size Share by Country (2017-2028) Figure 21. United States Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Opioid Induced Side Effects Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2028) Figure 25. Europe Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2028) Figure 26. Europe Opioid Induced Side Effects Treatment Market Size Share by Country (2017-2028) Figure 27. Germany Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Opioid Induced Side Effects Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Opioid Induced Side Effects Treatment Market Size Share by Region (2017-2028) Figure 37. China Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Opioid Induced Side Effects Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2028) Figure 45. Latin America Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2028) Figure 46. Latin America Opioid Induced Side Effects Treatment Market Size Share by Country (2017-2028) Figure 47. Mexico Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Opioid Induced Side Effects Treatment Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Opioid Induced Side Effects Treatment Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Opioid Induced Side Effects Treatment Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Opioid Induced Side Effects Treatment Market Size Share by Country (2017-2028) Figure 53. Turkey Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Opioid Induced Side Effects Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Shionogi Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2017-2022) Figure 57. Cubist Pharmaceuticals Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2017-2022) Figure 58. SLA Pharma Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2017-2022) Figure 59. AstraZeneca Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2017-2022) Figure 60. AIKO Biotechnology Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2017-2022) Figure 61. Progenics Pharmaceuticals Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2017-2022) Figure 62. Bottom-up and Top-down Approaches for This Report Figure 63. Data Triangulation Figure 64. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.